News
Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...
12h
WTEN Albany on MSNAlbany International Airport completes phase 1 of concourse upgradesThe Albany International Airport has completed the first phase of its Concourse A Rehabilitation Project. Phase one included ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VALORANT’s Esports Product Manager has revealed a list of tournaments which will offer direct qualification to Project ...
It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...
Ucore Rare Metals Inc. (OTCMKTS:UURAF) is one of the best rare earth stocks to buy now. On July 14, the company confirmed all ...
The African Development Bank (AFDB) said Phase 2 of its Special Agro-Industrial Processing Zones, which will cover the remaining 28 States, is scheduled to take off from September 2025.
Tampa leaders approve resolution for $1.83M contract for first phase of Sulphur Springs pool repairs
Tampa City Council approved a resolution a $1.83 million contract to begin repairs at Sulphur Springs Pool. FOX 13's Kylie ...
On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Eli Lilly stock beats Q2 estimates with strong sales but faces competitive risks and high valuation. Here's why investors may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results